Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-877-4 | CAS number: 89-04-3
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant study conducted according to internationally recognised test methods.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- Also compliant with Guideline for Screening Mutagenicity Testing of Chemicals Japan
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Trioctyl benzene-1,2,4-tricarboxylate
- EC Number:
- 201-877-4
- EC Name:
- Trioctyl benzene-1,2,4-tricarboxylate
- Cas Number:
- 89-04-3
- Molecular formula:
- C33H54O6
- IUPAC Name:
- 1,2,4-trioctyl benzene-1,2,4-tricarboxylate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Lot/batch No.: C-120
Method
Species / strainopen allclose all
- Species / strain / cell type:
- E. coli WP2 uvr A
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction (mixed induction rat liver preparation)
- Test concentrations with justification for top dose:
- Without S9 mix 0 313 625 1250 2500 &5000 ug/plate
With S9 mix 0 313 625 1250 2500 & 5000 ug/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: Substance is soluble in acetone.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- furylfuramide
- Remarks:
- TA100, TA98 in absence of S9 mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA1535 in absence of S9 mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- WP2 in absence of S9 mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA1537 in absence of S9 mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- All strains in the presence of S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation)
DURATION
- Preincubation period: 10h
- Exposure duration: 48h at 37 degrees C
- Expression time (cells in growth medium): 48h
- Selection time (if incubation with a selection agent): N/A
- Fixation time (start of exposure up to fixation or harvest of cells): N/A
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: plates/test: 3
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: not observed at doses of up to 5000 ug/plate with or without S9 - Evaluation criteria:
- An increase in colony count of more than 2 fold when compared with concurrent controls and/or a dose dependent increase in the colony count which is statistically significantly higher than the count for the controls.
- Statistics:
- No statistical analyses were done.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No
- Effects of osmolality: No
- Evaporation from medium: No data
- Water solubility: N/A
- Precipitation: No
- Other confounding effects: No
RANGE-FINDING/SCREENING STUDIES: yes range of doses tested 1.22-5000ug/plate.
COMPARISON WITH HISTORICAL CONTROL DATA:
ADDITIONAL INFORMATION ON CYTOTOXICITY: Toxicity was not observed at 313-5000 ug/plate - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1 - Results of reverse mutation test I
With (+) or |
Dose (µg/plate) |
Number of revertants Mean (±SD) |
||||
without(-) |
Base-pair substitution type |
Frameshift type |
||||
S9 mix |
TA100 |
TA1535 |
WP2 uvrA |
TA98 |
TA1537 |
|
|
0 |
105 (±3) |
15 (±5) |
34 (±4) |
23 (±4) |
9 (±2) |
|
313 |
106 (±6) |
17 (±4) |
33 (±7) |
23 (±4) |
10 (±2) |
S9 mix |
625 |
113 (±7) |
20 (±5) |
38 (±2) |
25 (±4) |
8 (±1) |
(-) |
1250 |
124 (±16) |
19 (±3) |
38 (±6) |
28 (±5) |
10 (±1) |
|
2500 |
123 (±12) |
21 (±2) |
36 (±6) |
26 (±2) |
8 (±2) |
|
5000 |
116 (±9) |
23 (±1) |
36 (±3) |
25 (±8) |
8 (±3) |
|
0 |
107 (±8) |
16 (±1) |
29 (±5) |
35 (±3) |
11 (±3) |
|
313 |
114 (±8) |
17 (±2) |
35 (±2) |
31 (±3) |
13 (±3) |
S9 mix |
625 |
115 (±12) |
20 (±2) |
42 (±2) |
35 (±2) |
11 (±1) |
(+) |
1250 |
116 (±10) |
20 (±1) |
43 (±5) |
39 (±3) |
12 (±0) |
|
2500 |
125 (±18) |
21 (±3) |
34 (±3) |
36 (±3) |
11 (±1) |
|
5000 |
131 (±24) |
21 (±3) |
37 (±3) |
39 (±3) |
12 (±2) |
+ve control |
Chemical |
AF-2 |
SA |
ENNG |
AF-2 |
9-AA |
S9 mix(-) |
Doseµg/plate |
0.01 |
0.5 |
2 |
0.1 |
80 |
|
Colonies/plate |
514 (±14) |
441 (±30) |
833 (± 42) |
549 (±40) |
313 (±6) |
+ve control |
Chemical |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
S9 mix(+) |
Doseµg/plate |
1 |
2 |
10 |
0.5 |
2 |
|
Colonies/plate |
1301 (±82) |
228 (±3) |
1092 (±28) |
461 (±10) |
189 (±13) |
AF-2 = 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide; SA = sodium azide; ENNG = N-ethyl-n’-nitro-N-nitrosoguanidine; 9-AA = 9-aminoacridine; 2 -AA = 2 -aminoanthracene
Table 2 - Results of reverse mutation test II
With (+) or |
Dose (µg/plate) |
Number of revertants Mean (±SD) |
||||
without(-) |
Base-pair substitution type |
Frameshift type |
||||
S9 mix |
TA100 |
TA1535 |
WP2 uvrA |
TA98 |
TA1537 |
|
|
0 |
151 (±5) |
11 (±2) |
33 (±2) |
20 (±3) |
8 (±2) |
|
313 |
130 (±6) |
10 (±1) |
41 (±5) |
18 (±2) |
8 (±1) |
S9 mix |
625 |
135 (±3) |
10 (±1) |
39 (±2) |
21 (±5) |
7 (±2) |
(-) |
1250 |
135 (±13) |
10 (±3) |
39 (±7) |
17 (±2) |
9 (±3) |
|
2500 |
142 (±6) |
10 (±1) |
42 (±1) |
19 (±2) |
11 (±1) |
|
5000 |
140 (±20) |
9 (±1) |
41 (±1) |
18 (±1) |
8 (±1) |
|
0 |
111 (±6) |
10 (±1) |
40 (±3) |
28 (±2) |
17 (±2) |
|
313 |
135 (±13) |
10 (±2) |
48 (±3) |
26 (±3) |
13 (±2) |
S9 mix |
625 |
151 (±17) |
10 (±1) |
45 (±8) |
29 (±5) |
16 (±3) |
(+) |
1250 |
135 (±24) |
12 (±1) |
45 (±7) |
30 (±4) |
13 (±4) |
|
2500 |
146 (±8) |
10 (±1) |
41 (±4) |
31 (±10) |
16 (±4) |
|
5000 |
140 (±5) |
12 (±2) |
39 (±2) |
29 (±3) |
13 (±3) |
+ve control |
Chemical |
AF-2 |
SA |
ENNG |
AF-2 |
9-AA |
S9 mix(-) |
Doseµg/plate |
0.01 |
0.5 |
2 |
0.1 |
80 |
|
Colonies/plate |
633 (±27) |
485 (±8) |
929 (±39) |
531 (±53) |
436 (±15) |
+ve control |
Chemical |
2-AA |
2-AA |
2-AA |
2-AA |
2-AA |
S9 mix(+) |
Doseµg/plate |
1 |
2 |
10 |
0.5 |
2 |
|
Colonies/plate |
1230 (±38) |
250 (±2) |
1305 (±68) |
510 (±19) |
190 (±27) |
AF-2 = 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide; SA = sodium azide; ENNG = N-ethyl-n’-nitro-N-nitrosoguanidine; 9-AA = 9-aminoacridine; 2 -AA = 2 -aminoanthracene
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Based on results under the conditions of this test the substance was not considered to be mutagenic to Salmonella typhimurium TA100, TA 1535, TA98, TA1537 & E coli WP2 uvrA. - Executive summary:
A bacterial reverse mutation assay (Ames test) has been undertaken following OECD test methods.
The substance does not induce reverse mutation in Salmonella typhimurium or Escherichia coli.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
